Pharma & Healthcare
Global Blood Plasma Derivatives Market Research Report 2025
- Sep 09, 25
- ID: 498207
- Pages: 96
- Figures: 100
- Views: 4
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Derivatives.
The Blood Plasma Derivatives market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Plasma Derivatives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Plasma Derivatives companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
Immune Globulin
Coagulation Factor
Albumin
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Plasma Derivatives company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Blood Plasma Derivatives market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Plasma Derivatives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Plasma Derivatives companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
Immune Globulin
Coagulation Factor
Albumin
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Plasma Derivatives company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Plasma Derivatives Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Other
1.3 Market by Application
1.3.1 Global Blood Plasma Derivatives Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Plasma Derivatives Market Perspective (2020-2031)
2.2 Global Blood Plasma Derivatives Growth Trends by Region
2.2.1 Global Blood Plasma Derivatives Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Blood Plasma Derivatives Historic Market Size by Region (2020-2025)
2.2.3 Blood Plasma Derivatives Forecasted Market Size by Region (2026-2031)
2.3 Blood Plasma Derivatives Market Dynamics
2.3.1 Blood Plasma Derivatives Industry Trends
2.3.2 Blood Plasma Derivatives Market Drivers
2.3.3 Blood Plasma Derivatives Market Challenges
2.3.4 Blood Plasma Derivatives Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Plasma Derivatives Players by Revenue
3.1.1 Global Top Blood Plasma Derivatives Players by Revenue (2020-2025)
3.1.2 Global Blood Plasma Derivatives Revenue Market Share by Players (2020-2025)
3.2 Global Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Blood Plasma Derivatives Revenue
3.4 Global Blood Plasma Derivatives Market Concentration Ratio
3.4.1 Global Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Derivatives Revenue in 2024
3.5 Global Key Players of Blood Plasma Derivatives Head office and Area Served
3.6 Global Key Players of Blood Plasma Derivatives, Product and Application
3.7 Global Key Players of Blood Plasma Derivatives, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Plasma Derivatives Breakdown Data by Type
4.1 Global Blood Plasma Derivatives Historic Market Size by Type (2020-2025)
4.2 Global Blood Plasma Derivatives Forecasted Market Size by Type (2026-2031)
5 Blood Plasma Derivatives Breakdown Data by Application
5.1 Global Blood Plasma Derivatives Historic Market Size by Application (2020-2025)
5.2 Global Blood Plasma Derivatives Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Blood Plasma Derivatives Market Size (2020-2031)
6.2 North America Blood Plasma Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Blood Plasma Derivatives Market Size by Country (2020-2025)
6.4 North America Blood Plasma Derivatives Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Plasma Derivatives Market Size (2020-2031)
7.2 Europe Blood Plasma Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Blood Plasma Derivatives Market Size by Country (2020-2025)
7.4 Europe Blood Plasma Derivatives Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Plasma Derivatives Market Size (2020-2031)
8.2 Asia-Pacific Blood Plasma Derivatives Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2020-2025)
8.4 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Plasma Derivatives Market Size (2020-2031)
9.2 Latin America Blood Plasma Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Blood Plasma Derivatives Market Size by Country (2020-2025)
9.4 Latin America Blood Plasma Derivatives Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Plasma Derivatives Market Size (2020-2031)
10.2 Middle East & Africa Blood Plasma Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2020-2025)
10.4 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Blood Plasma Derivatives Introduction
11.1.4 Takeda Revenue in Blood Plasma Derivatives Business (2020-2025)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Blood Plasma Derivatives Introduction
11.2.4 CSL Revenue in Blood Plasma Derivatives Business (2020-2025)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Details
11.3.2 Grifols Business Overview
11.3.3 Grifols Blood Plasma Derivatives Introduction
11.3.4 Grifols Revenue in Blood Plasma Derivatives Business (2020-2025)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Blood Plasma Derivatives Introduction
11.4.4 Octapharma Revenue in Blood Plasma Derivatives Business (2020-2025)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Details
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Blood Plasma Derivatives Introduction
11.5.4 Kedrion Revenue in Blood Plasma Derivatives Business (2020-2025)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Details
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Blood Plasma Derivatives Introduction
11.6.4 LFB Group Revenue in Blood Plasma Derivatives Business (2020-2025)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Details
11.7.2 Biotest Business Overview
11.7.3 Biotest Blood Plasma Derivatives Introduction
11.7.4 Biotest Revenue in Blood Plasma Derivatives Business (2020-2025)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Details
11.8.2 BPL Business Overview
11.8.3 BPL Blood Plasma Derivatives Introduction
11.8.4 BPL Revenue in Blood Plasma Derivatives Business (2020-2025)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Details
11.9.2 RAAS Business Overview
11.9.3 RAAS Blood Plasma Derivatives Introduction
11.9.4 RAAS Revenue in Blood Plasma Derivatives Business (2020-2025)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Details
11.10.2 CBPO Business Overview
11.10.3 CBPO Blood Plasma Derivatives Introduction
11.10.4 CBPO Revenue in Blood Plasma Derivatives Business (2020-2025)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Details
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Blood Plasma Derivatives Introduction
11.11.4 Hualan Bio Revenue in Blood Plasma Derivatives Business (2020-2025)
11.11.5 Hualan Bio Recent Development
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Details
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Blood Plasma Derivatives Introduction
11.12.4 Tiantan Bio Revenue in Blood Plasma Derivatives Business (2020-2025)
11.12.5 Tiantan Bio Recent Development
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Details
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Blood Plasma Derivatives Introduction
11.13.4 Shuanglin Bio Revenue in Blood Plasma Derivatives Business (2020-2025)
11.13.5 Shuanglin Bio Recent Development
11.14 Boya Bio
11.14.1 Boya Bio Company Details
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Blood Plasma Derivatives Introduction
11.14.4 Boya Bio Revenue in Blood Plasma Derivatives Business (2020-2025)
11.14.5 Boya Bio Recent Development
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Details
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Blood Plasma Derivatives Introduction
11.15.4 Yuanda Shuyang Revenue in Blood Plasma Derivatives Business (2020-2025)
11.15.5 Yuanda Shuyang Recent Development
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Details
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Blood Plasma Derivatives Introduction
11.16.4 Weiguang Bio Revenue in Blood Plasma Derivatives Business (2020-2025)
11.16.5 Weiguang Bio Recent Development
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Details
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Blood Plasma Derivatives Introduction
11.17.4 Nanyue Bio Revenue in Blood Plasma Derivatives Business (2020-2025)
11.17.5 Nanyue Bio Recent Development
11.18 KM Biologics
11.18.1 KM Biologics Company Details
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Blood Plasma Derivatives Introduction
11.18.4 KM Biologics Revenue in Blood Plasma Derivatives Business (2020-2025)
11.18.5 KM Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Plasma Derivatives Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Other
1.3 Market by Application
1.3.1 Global Blood Plasma Derivatives Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Plasma Derivatives Market Perspective (2020-2031)
2.2 Global Blood Plasma Derivatives Growth Trends by Region
2.2.1 Global Blood Plasma Derivatives Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Blood Plasma Derivatives Historic Market Size by Region (2020-2025)
2.2.3 Blood Plasma Derivatives Forecasted Market Size by Region (2026-2031)
2.3 Blood Plasma Derivatives Market Dynamics
2.3.1 Blood Plasma Derivatives Industry Trends
2.3.2 Blood Plasma Derivatives Market Drivers
2.3.3 Blood Plasma Derivatives Market Challenges
2.3.4 Blood Plasma Derivatives Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Plasma Derivatives Players by Revenue
3.1.1 Global Top Blood Plasma Derivatives Players by Revenue (2020-2025)
3.1.2 Global Blood Plasma Derivatives Revenue Market Share by Players (2020-2025)
3.2 Global Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Blood Plasma Derivatives Revenue
3.4 Global Blood Plasma Derivatives Market Concentration Ratio
3.4.1 Global Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Derivatives Revenue in 2024
3.5 Global Key Players of Blood Plasma Derivatives Head office and Area Served
3.6 Global Key Players of Blood Plasma Derivatives, Product and Application
3.7 Global Key Players of Blood Plasma Derivatives, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Plasma Derivatives Breakdown Data by Type
4.1 Global Blood Plasma Derivatives Historic Market Size by Type (2020-2025)
4.2 Global Blood Plasma Derivatives Forecasted Market Size by Type (2026-2031)
5 Blood Plasma Derivatives Breakdown Data by Application
5.1 Global Blood Plasma Derivatives Historic Market Size by Application (2020-2025)
5.2 Global Blood Plasma Derivatives Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Blood Plasma Derivatives Market Size (2020-2031)
6.2 North America Blood Plasma Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Blood Plasma Derivatives Market Size by Country (2020-2025)
6.4 North America Blood Plasma Derivatives Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Plasma Derivatives Market Size (2020-2031)
7.2 Europe Blood Plasma Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Blood Plasma Derivatives Market Size by Country (2020-2025)
7.4 Europe Blood Plasma Derivatives Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Plasma Derivatives Market Size (2020-2031)
8.2 Asia-Pacific Blood Plasma Derivatives Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2020-2025)
8.4 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Plasma Derivatives Market Size (2020-2031)
9.2 Latin America Blood Plasma Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Blood Plasma Derivatives Market Size by Country (2020-2025)
9.4 Latin America Blood Plasma Derivatives Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Plasma Derivatives Market Size (2020-2031)
10.2 Middle East & Africa Blood Plasma Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2020-2025)
10.4 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Blood Plasma Derivatives Introduction
11.1.4 Takeda Revenue in Blood Plasma Derivatives Business (2020-2025)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Blood Plasma Derivatives Introduction
11.2.4 CSL Revenue in Blood Plasma Derivatives Business (2020-2025)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Details
11.3.2 Grifols Business Overview
11.3.3 Grifols Blood Plasma Derivatives Introduction
11.3.4 Grifols Revenue in Blood Plasma Derivatives Business (2020-2025)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Blood Plasma Derivatives Introduction
11.4.4 Octapharma Revenue in Blood Plasma Derivatives Business (2020-2025)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Details
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Blood Plasma Derivatives Introduction
11.5.4 Kedrion Revenue in Blood Plasma Derivatives Business (2020-2025)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Details
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Blood Plasma Derivatives Introduction
11.6.4 LFB Group Revenue in Blood Plasma Derivatives Business (2020-2025)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Details
11.7.2 Biotest Business Overview
11.7.3 Biotest Blood Plasma Derivatives Introduction
11.7.4 Biotest Revenue in Blood Plasma Derivatives Business (2020-2025)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Details
11.8.2 BPL Business Overview
11.8.3 BPL Blood Plasma Derivatives Introduction
11.8.4 BPL Revenue in Blood Plasma Derivatives Business (2020-2025)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Details
11.9.2 RAAS Business Overview
11.9.3 RAAS Blood Plasma Derivatives Introduction
11.9.4 RAAS Revenue in Blood Plasma Derivatives Business (2020-2025)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Details
11.10.2 CBPO Business Overview
11.10.3 CBPO Blood Plasma Derivatives Introduction
11.10.4 CBPO Revenue in Blood Plasma Derivatives Business (2020-2025)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Details
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Blood Plasma Derivatives Introduction
11.11.4 Hualan Bio Revenue in Blood Plasma Derivatives Business (2020-2025)
11.11.5 Hualan Bio Recent Development
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Details
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Blood Plasma Derivatives Introduction
11.12.4 Tiantan Bio Revenue in Blood Plasma Derivatives Business (2020-2025)
11.12.5 Tiantan Bio Recent Development
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Details
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Blood Plasma Derivatives Introduction
11.13.4 Shuanglin Bio Revenue in Blood Plasma Derivatives Business (2020-2025)
11.13.5 Shuanglin Bio Recent Development
11.14 Boya Bio
11.14.1 Boya Bio Company Details
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Blood Plasma Derivatives Introduction
11.14.4 Boya Bio Revenue in Blood Plasma Derivatives Business (2020-2025)
11.14.5 Boya Bio Recent Development
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Details
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Blood Plasma Derivatives Introduction
11.15.4 Yuanda Shuyang Revenue in Blood Plasma Derivatives Business (2020-2025)
11.15.5 Yuanda Shuyang Recent Development
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Details
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Blood Plasma Derivatives Introduction
11.16.4 Weiguang Bio Revenue in Blood Plasma Derivatives Business (2020-2025)
11.16.5 Weiguang Bio Recent Development
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Details
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Blood Plasma Derivatives Introduction
11.17.4 Nanyue Bio Revenue in Blood Plasma Derivatives Business (2020-2025)
11.17.5 Nanyue Bio Recent Development
11.18 KM Biologics
11.18.1 KM Biologics Company Details
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Blood Plasma Derivatives Introduction
11.18.4 KM Biologics Revenue in Blood Plasma Derivatives Business (2020-2025)
11.18.5 KM Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Blood Plasma Derivatives Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immune Globulin
Table 3. Key Players of Coagulation Factor
Table 4. Key Players of Albumin
Table 5. Key Players of Other
Table 6. Global Blood Plasma Derivatives Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Blood Plasma Derivatives Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Blood Plasma Derivatives Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Blood Plasma Derivatives Market Share by Region (2020-2025)
Table 10. Global Blood Plasma Derivatives Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Blood Plasma Derivatives Market Share by Region (2026-2031)
Table 12. Blood Plasma Derivatives Market Trends
Table 13. Blood Plasma Derivatives Market Drivers
Table 14. Blood Plasma Derivatives Market Challenges
Table 15. Blood Plasma Derivatives Market Restraints
Table 16. Global Blood Plasma Derivatives Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Blood Plasma Derivatives Market Share by Players (2020-2025)
Table 18. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2024)
Table 19. Ranking of Global Top Blood Plasma Derivatives Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Blood Plasma Derivatives Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Blood Plasma Derivatives, Headquarters and Area Served
Table 22. Global Key Players of Blood Plasma Derivatives, Product and Application
Table 23. Global Key Players of Blood Plasma Derivatives, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Blood Plasma Derivatives Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Blood Plasma Derivatives Revenue Market Share by Type (2020-2025)
Table 27. Global Blood Plasma Derivatives Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Blood Plasma Derivatives Revenue Market Share by Type (2026-2031)
Table 29. Global Blood Plasma Derivatives Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Blood Plasma Derivatives Revenue Market Share by Application (2020-2025)
Table 31. Global Blood Plasma Derivatives Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Blood Plasma Derivatives Revenue Market Share by Application (2026-2031)
Table 33. North America Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Blood Plasma Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Blood Plasma Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Blood Plasma Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Blood Plasma Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Blood Plasma Derivatives Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Blood Plasma Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Blood Plasma Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 48. Takeda Company Details
Table 49. Takeda Business Overview
Table 50. Takeda Blood Plasma Derivatives Product
Table 51. Takeda Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 52. Takeda Recent Development
Table 53. CSL Company Details
Table 54. CSL Business Overview
Table 55. CSL Blood Plasma Derivatives Product
Table 56. CSL Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 57. CSL Recent Development
Table 58. Grifols Company Details
Table 59. Grifols Business Overview
Table 60. Grifols Blood Plasma Derivatives Product
Table 61. Grifols Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 62. Grifols Recent Development
Table 63. Octapharma Company Details
Table 64. Octapharma Business Overview
Table 65. Octapharma Blood Plasma Derivatives Product
Table 66. Octapharma Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 67. Octapharma Recent Development
Table 68. Kedrion Company Details
Table 69. Kedrion Business Overview
Table 70. Kedrion Blood Plasma Derivatives Product
Table 71. Kedrion Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 72. Kedrion Recent Development
Table 73. LFB Group Company Details
Table 74. LFB Group Business Overview
Table 75. LFB Group Blood Plasma Derivatives Product
Table 76. LFB Group Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 77. LFB Group Recent Development
Table 78. Biotest Company Details
Table 79. Biotest Business Overview
Table 80. Biotest Blood Plasma Derivatives Product
Table 81. Biotest Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 82. Biotest Recent Development
Table 83. BPL Company Details
Table 84. BPL Business Overview
Table 85. BPL Blood Plasma Derivatives Product
Table 86. BPL Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 87. BPL Recent Development
Table 88. RAAS Company Details
Table 89. RAAS Business Overview
Table 90. RAAS Blood Plasma Derivatives Product
Table 91. RAAS Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 92. RAAS Recent Development
Table 93. CBPO Company Details
Table 94. CBPO Business Overview
Table 95. CBPO Blood Plasma Derivatives Product
Table 96. CBPO Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 97. CBPO Recent Development
Table 98. Hualan Bio Company Details
Table 99. Hualan Bio Business Overview
Table 100. Hualan Bio Blood Plasma Derivatives Product
Table 101. Hualan Bio Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 102. Hualan Bio Recent Development
Table 103. Tiantan Bio Company Details
Table 104. Tiantan Bio Business Overview
Table 105. Tiantan Bio Blood Plasma Derivatives Product
Table 106. Tiantan Bio Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 107. Tiantan Bio Recent Development
Table 108. Shuanglin Bio Company Details
Table 109. Shuanglin Bio Business Overview
Table 110. Shuanglin Bio Blood Plasma Derivatives Product
Table 111. Shuanglin Bio Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 112. Shuanglin Bio Recent Development
Table 113. Boya Bio Company Details
Table 114. Boya Bio Business Overview
Table 115. Boya Bio Blood Plasma Derivatives Product
Table 116. Boya Bio Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 117. Boya Bio Recent Development
Table 118. Yuanda Shuyang Company Details
Table 119. Yuanda Shuyang Business Overview
Table 120. Yuanda Shuyang Blood Plasma Derivatives Product
Table 121. Yuanda Shuyang Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 122. Yuanda Shuyang Recent Development
Table 123. Weiguang Bio Company Details
Table 124. Weiguang Bio Business Overview
Table 125. Weiguang Bio Blood Plasma Derivatives Product
Table 126. Weiguang Bio Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 127. Weiguang Bio Recent Development
Table 128. Nanyue Bio Company Details
Table 129. Nanyue Bio Business Overview
Table 130. Nanyue Bio Blood Plasma Derivatives Product
Table 131. Nanyue Bio Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 132. Nanyue Bio Recent Development
Table 133. KM Biologics Company Details
Table 134. KM Biologics Business Overview
Table 135. KM Biologics Blood Plasma Derivatives Product
Table 136. KM Biologics Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 137. KM Biologics Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Blood Plasma Derivatives Picture
Figure 2. Global Blood Plasma Derivatives Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Blood Plasma Derivatives Market Share by Type: 2024 VS 2031
Figure 4. Immune Globulin Features
Figure 5. Coagulation Factor Features
Figure 6. Albumin Features
Figure 7. Other Features
Figure 8. Global Blood Plasma Derivatives Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Blood Plasma Derivatives Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Other Case Studies
Figure 13. Blood Plasma Derivatives Report Years Considered
Figure 14. Global Blood Plasma Derivatives Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Blood Plasma Derivatives Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Blood Plasma Derivatives Market Share by Region: 2024 VS 2031
Figure 17. Global Blood Plasma Derivatives Market Share by Players in 2024
Figure 18. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Blood Plasma Derivatives Revenue in 2024
Figure 20. North America Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Blood Plasma Derivatives Market Share by Country (2020-2031)
Figure 22. United States Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Blood Plasma Derivatives Market Share by Country (2020-2031)
Figure 26. Germany Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Blood Plasma Derivatives Market Share by Region (2020-2031)
Figure 34. China Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Blood Plasma Derivatives Market Share by Country (2020-2031)
Figure 42. Mexico Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Blood Plasma Derivatives Market Share by Country (2020-2031)
Figure 46. Turkey Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Takeda Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 50. CSL Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 51. Grifols Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 52. Octapharma Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 53. Kedrion Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 54. LFB Group Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 55. Biotest Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 56. BPL Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 57. RAAS Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 58. CBPO Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 59. Hualan Bio Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 60. Tiantan Bio Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 61. Shuanglin Bio Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 62. Boya Bio Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 63. Yuanda Shuyang Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 64. Weiguang Bio Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 65. Nanyue Bio Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 66. KM Biologics Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Blood Plasma Derivatives Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immune Globulin
Table 3. Key Players of Coagulation Factor
Table 4. Key Players of Albumin
Table 5. Key Players of Other
Table 6. Global Blood Plasma Derivatives Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Blood Plasma Derivatives Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Blood Plasma Derivatives Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Blood Plasma Derivatives Market Share by Region (2020-2025)
Table 10. Global Blood Plasma Derivatives Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Blood Plasma Derivatives Market Share by Region (2026-2031)
Table 12. Blood Plasma Derivatives Market Trends
Table 13. Blood Plasma Derivatives Market Drivers
Table 14. Blood Plasma Derivatives Market Challenges
Table 15. Blood Plasma Derivatives Market Restraints
Table 16. Global Blood Plasma Derivatives Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Blood Plasma Derivatives Market Share by Players (2020-2025)
Table 18. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2024)
Table 19. Ranking of Global Top Blood Plasma Derivatives Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Blood Plasma Derivatives Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Blood Plasma Derivatives, Headquarters and Area Served
Table 22. Global Key Players of Blood Plasma Derivatives, Product and Application
Table 23. Global Key Players of Blood Plasma Derivatives, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Blood Plasma Derivatives Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Blood Plasma Derivatives Revenue Market Share by Type (2020-2025)
Table 27. Global Blood Plasma Derivatives Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Blood Plasma Derivatives Revenue Market Share by Type (2026-2031)
Table 29. Global Blood Plasma Derivatives Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Blood Plasma Derivatives Revenue Market Share by Application (2020-2025)
Table 31. Global Blood Plasma Derivatives Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Blood Plasma Derivatives Revenue Market Share by Application (2026-2031)
Table 33. North America Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Blood Plasma Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Blood Plasma Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Blood Plasma Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Blood Plasma Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Blood Plasma Derivatives Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Blood Plasma Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Blood Plasma Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 48. Takeda Company Details
Table 49. Takeda Business Overview
Table 50. Takeda Blood Plasma Derivatives Product
Table 51. Takeda Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 52. Takeda Recent Development
Table 53. CSL Company Details
Table 54. CSL Business Overview
Table 55. CSL Blood Plasma Derivatives Product
Table 56. CSL Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 57. CSL Recent Development
Table 58. Grifols Company Details
Table 59. Grifols Business Overview
Table 60. Grifols Blood Plasma Derivatives Product
Table 61. Grifols Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 62. Grifols Recent Development
Table 63. Octapharma Company Details
Table 64. Octapharma Business Overview
Table 65. Octapharma Blood Plasma Derivatives Product
Table 66. Octapharma Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 67. Octapharma Recent Development
Table 68. Kedrion Company Details
Table 69. Kedrion Business Overview
Table 70. Kedrion Blood Plasma Derivatives Product
Table 71. Kedrion Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 72. Kedrion Recent Development
Table 73. LFB Group Company Details
Table 74. LFB Group Business Overview
Table 75. LFB Group Blood Plasma Derivatives Product
Table 76. LFB Group Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 77. LFB Group Recent Development
Table 78. Biotest Company Details
Table 79. Biotest Business Overview
Table 80. Biotest Blood Plasma Derivatives Product
Table 81. Biotest Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 82. Biotest Recent Development
Table 83. BPL Company Details
Table 84. BPL Business Overview
Table 85. BPL Blood Plasma Derivatives Product
Table 86. BPL Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 87. BPL Recent Development
Table 88. RAAS Company Details
Table 89. RAAS Business Overview
Table 90. RAAS Blood Plasma Derivatives Product
Table 91. RAAS Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 92. RAAS Recent Development
Table 93. CBPO Company Details
Table 94. CBPO Business Overview
Table 95. CBPO Blood Plasma Derivatives Product
Table 96. CBPO Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 97. CBPO Recent Development
Table 98. Hualan Bio Company Details
Table 99. Hualan Bio Business Overview
Table 100. Hualan Bio Blood Plasma Derivatives Product
Table 101. Hualan Bio Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 102. Hualan Bio Recent Development
Table 103. Tiantan Bio Company Details
Table 104. Tiantan Bio Business Overview
Table 105. Tiantan Bio Blood Plasma Derivatives Product
Table 106. Tiantan Bio Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 107. Tiantan Bio Recent Development
Table 108. Shuanglin Bio Company Details
Table 109. Shuanglin Bio Business Overview
Table 110. Shuanglin Bio Blood Plasma Derivatives Product
Table 111. Shuanglin Bio Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 112. Shuanglin Bio Recent Development
Table 113. Boya Bio Company Details
Table 114. Boya Bio Business Overview
Table 115. Boya Bio Blood Plasma Derivatives Product
Table 116. Boya Bio Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 117. Boya Bio Recent Development
Table 118. Yuanda Shuyang Company Details
Table 119. Yuanda Shuyang Business Overview
Table 120. Yuanda Shuyang Blood Plasma Derivatives Product
Table 121. Yuanda Shuyang Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 122. Yuanda Shuyang Recent Development
Table 123. Weiguang Bio Company Details
Table 124. Weiguang Bio Business Overview
Table 125. Weiguang Bio Blood Plasma Derivatives Product
Table 126. Weiguang Bio Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 127. Weiguang Bio Recent Development
Table 128. Nanyue Bio Company Details
Table 129. Nanyue Bio Business Overview
Table 130. Nanyue Bio Blood Plasma Derivatives Product
Table 131. Nanyue Bio Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 132. Nanyue Bio Recent Development
Table 133. KM Biologics Company Details
Table 134. KM Biologics Business Overview
Table 135. KM Biologics Blood Plasma Derivatives Product
Table 136. KM Biologics Revenue in Blood Plasma Derivatives Business (2020-2025) & (US$ Million)
Table 137. KM Biologics Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Blood Plasma Derivatives Picture
Figure 2. Global Blood Plasma Derivatives Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Blood Plasma Derivatives Market Share by Type: 2024 VS 2031
Figure 4. Immune Globulin Features
Figure 5. Coagulation Factor Features
Figure 6. Albumin Features
Figure 7. Other Features
Figure 8. Global Blood Plasma Derivatives Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Blood Plasma Derivatives Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Other Case Studies
Figure 13. Blood Plasma Derivatives Report Years Considered
Figure 14. Global Blood Plasma Derivatives Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Blood Plasma Derivatives Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Blood Plasma Derivatives Market Share by Region: 2024 VS 2031
Figure 17. Global Blood Plasma Derivatives Market Share by Players in 2024
Figure 18. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Blood Plasma Derivatives Revenue in 2024
Figure 20. North America Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Blood Plasma Derivatives Market Share by Country (2020-2031)
Figure 22. United States Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Blood Plasma Derivatives Market Share by Country (2020-2031)
Figure 26. Germany Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Blood Plasma Derivatives Market Share by Region (2020-2031)
Figure 34. China Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Blood Plasma Derivatives Market Share by Country (2020-2031)
Figure 42. Mexico Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Blood Plasma Derivatives Market Share by Country (2020-2031)
Figure 46. Turkey Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Blood Plasma Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Takeda Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 50. CSL Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 51. Grifols Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 52. Octapharma Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 53. Kedrion Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 54. LFB Group Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 55. Biotest Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 56. BPL Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 57. RAAS Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 58. CBPO Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 59. Hualan Bio Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 60. Tiantan Bio Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 61. Shuanglin Bio Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 62. Boya Bio Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 63. Yuanda Shuyang Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 64. Weiguang Bio Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 65. Nanyue Bio Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 66. KM Biologics Revenue Growth Rate in Blood Plasma Derivatives Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232